2024. Reply to comment by Arber C, et al. on: Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland. Swiss Medical Weekly. 154, 10 (Oct. 2024), 3958. DOI:https://doi.org/10.57187/s.3958.